Journal Title：Clinica Chimica Acta

The Official Journal of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC)

Clinica Chimica Acta is a high-quality journal which publishes original Research Communications in the field of clinical chemistry and laboratory medicine, defined as the diagnostic application of chemistry, biochemistry, immunochemistry, biochemical aspects of hematology, toxicology, and molecular biology to the study of human disease in body fluids and cells.

The objective of the journal is to publish novel information leading to a better understanding of biological mechanisms of human diseases, their prevention, diagnosis, and patient management. Reports of an applied clinical character are also welcome. Papers concerned with normal metabolic processes or with constituents of normal cells or body fluids, such as reports of experimental or clinical studies in animals, are only considered when they are clearly and directly relevant to human disease. Evaluation of commercial products have a low priority for publication, unless they are novel or represent a technological breakthrough. Studies dealing with effects of drugs and natural products and studies dealing with the redox status in various diseases are not within the journal's scope. Development and evaluation of novel analytical methodologies where applicable to diagnostic clinical chemistry and laboratory medicine, including point-of-care testing, and topics on laboratory management and informatics will also be considered. Studies focused on emerging diagnostic technologies and (big) data analysis procedures including digitalization, mobile Health, and artificial Intelligence applied to Laboratory Medicine are also of interest.

国际临床化学和检验医学联合会 (IFCC) 官方期刊

Clinica Chimica Acta 是一本高质量期刊，发表临床化学和实验室医学领域的原创研究通讯，定义为化学、生物化学、免疫化学、血液学、毒理学和分子生物学的生化方面的诊断应用人体体液和细胞疾病的研究。

该杂志的目标是发表新的信息，以便更好地了解人类疾病的生物学机制、预防、诊断和患者管理。也欢迎应用临床特征的报告。涉及正常代谢过程或正常细胞或体液成分的论文，例如动物实验或临床研究的报告，只有在与人类疾病明确和直接相关时才会被考虑。商业产品的评估对于出版的优先级较低，除非它们是新颖的或代表技术突破。涉及药物和天然产物影响的研究以及涉及各种疾病中氧化还原状态的研究不在该期刊的范围内。还将考虑开发和评估适用于诊断临床化学和实验室医学的新型分析方法，包括即时检测，以及实验室管理和信息学主题。关注新兴诊断技术和（大）数据分析程序（包括应用于检验医学的数字化、移动健康和人工智能）的研究也很受关注。